Simone N Koole

6PUBLICATIONS
9CO-AUTHORS
Haematological tumoursMedical biotechnology diagnostics (incl. biosensors)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 20, 2022
Reply to: Comments on "Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer: Results from the phase III OVHIPEC trial".

Simone N Koole, Philip C Schouten, Willemien J van Driel

|May 18, 2022
Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer: Results from the phase III OVHIPEC trial.

Simone N Koole, Philip C Schouten, Jan Hauke

|Apr 12, 2022
Cell-Free DNA at Diagnosis for Stage IV Non-Small Cell Lung Cancer: Costs, Time to Diagnosis and Clinical Relevance.

Simone N Koole, Daan C L Vessies, Milou M F Schuurbiers

|Oct 13, 2020
Central radiology assessment of the randomized phase III open-label OVHIPEC-1 trial in ovarian cancer.

Simone N Koole, Leigh Bruijs, Cristina Fabris

|Mar 25, 2020
Primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: OVHIPEC-2, a phase III randomized clinical trial.

Simone Koole, Ruby van Stein, Karolina Sikorska

|Jan 23, 2020
Hyperthermic intraperitoneal chemotherapy for ovarian cancer: The heat is on.

Simone N Koole, Willemien J van Driel, Gabe S Sonke

Pageof 1

Frequent Collaborators

2 joint publications

Gabe Sonke

2 joint publications

Willemien J van Driel

2 joint publications

Sabine C Linn

1 joint publications

Daan C L Vessies